TRINI TRAN: Open Payments
NPI 1477164846 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,325 in 174 payments from 23 companies in 2025. Trend: 2023 $112 · 2024 $2,827 · 2025 $3,325
Food & beverage: $3,325
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 12 | $600 |
| Ascensia Diabetes Care Us Inc. | 33 | $528 |
| Dexcom, Inc. | 26 | $303 |
| Amgen Inc. | 16 | $276 |
| SANOFI-AVENTIS U.S. LLC | 8 | $210 |
| Lilly USA, LLC | 13 | $209 |
| Novo Nordisk Inc | 12 | $189 |
| Tandem Diabetes Care, Inc. | 7 | $177 |
| ABBVIE INC. | 12 | $143 |
| Corcept Therapeutics | 8 | $136 |
Products named: Omnipod, Dexcom G6 Transmitter, TZIELD, t:slim X2 Insulin Pump with Control-IQ, Korlym, EVENITY, MOUNJARO, TEPEZZA.
Industry payments across TX — which companies pay providers there.
